Microbiome & Immunology of Barrier Tissues
The vast landscape of microbes and microbial products that bathe our body surfaces and mucosae remains a major frontier at the interface of immunology and microbiology. Microbiome research in the track includes efforts to define how microbial-derived products affect immune and epithelial biology and how immune cells remain poised at barriers to respond to pathogens while avoiding detrimental responses against commensals.
Faculty
Sterling Professor of Immunobiology; Investigator, Howard Hughes Medical Institute
Associate Professor of Laboratory Medicine and Immunobiology
Assistant Professor of Medicine (Infectious Diseases)
C.N.H. Long Professor of Microbial Pathogenesis and Director of Microbial Sciences Institute; Chair, Microbial Pathogenesis
William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology; Chair, Neurology; Neurologist-in-Chief, Yale New Haven Hospital
Sterling Professor of Immunobiology and Professor of Dermatology and of Molecular, Cellular, and Developmental Biology and of Epidemiology (Microbial Diseases); Investigator, Howard Hughes Medical Institute, (HHMI)
Sterling Professor of Immunobiology; Investigator, Howard Hughes Medical Institute
Bayer Professor of Translational Medicine and Professor of Immunobiology, Pathology and Dermatology; Director, Human and Translational Immunology Program; Vice-Chair, Dept. of Immunobiology for the Section of Human and Translational Immunology
Associate Professor Term; Medical Director, Immune Monitoring Core Facility